Viewing Study NCT02612194


Ignite Creation Date: 2025-12-25 @ 1:43 AM
Ignite Modification Date: 2026-02-26 @ 12:37 AM
Study NCT ID: NCT02612194
Status: TERMINATED
Last Update Posted: 2022-11-03
First Post: 2015-11-19
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: LCI-GU-URO-CRI-001: Crizotinib in Patients With c-MET or RON-Positive Metastatic Urothelial Cancer
Sponsor: Wake Forest University Health Sciences
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: LCI-GU-URO-CRI-001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View